HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Xing-Quan Zhao Selected Research
Xing-Quan Zhao Research Topics
Disease
29
Stroke (Strokes)
11/2023 - 10/2008
21
Ischemic Stroke
11/2023 - 02/2012
7
Atrial Fibrillation
02/2023 - 08/2010
6
Transient Ischemic Attack
08/2021 - 10/2008
3
Hypertension (High Blood Pressure)
02/2023 - 08/2021
3
Cerebral Infarction
06/2022 - 10/2008
2
Inflammation (Inflammations)
11/2023 - 06/2022
2
Peripheral Vascular Diseases (Peripheral Vascular Disease)
02/2023 - 10/2022
2
Deglutition Disorders (Dysphagia)
02/2023 - 01/2021
2
Dyslipidemias (Dyslipidemia)
10/2022 - 08/2021
2
Hematoma
07/2014 - 12/2012
2
Cerebral Hemorrhage
06/2014 - 12/2012
1
Infections
01/2023
1
Hyperlipidemias (Hyperlipidemia)
01/2023
1
Venous Thrombosis (Deep-Vein Thrombosis)
10/2022
1
Atherosclerotic Plaque (Atheroma)
06/2022
1
Infarction (Infarctions)
01/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2021
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
08/2021
1
Thromboembolism
01/2021
1
Diabetes Mellitus
10/2019
1
Proteinuria
09/2019
1
Pathologic Constriction (Stenosis)
01/2016
1
Anemia
07/2014
1
Carotid Stenosis (Carotid Artery Stenosis)
12/2012
1
Coronary Disease (Coronary Heart Disease)
03/2012
Drug/Important Bio-Agent (IBA)
7
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2023 - 01/2013
4
Biomarkers (Surrogate Marker)
IBA
11/2023 - 12/2012
4
oxidized low density lipoprotein
IBA
01/2023 - 12/2012
4
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
10/2019 - 10/2008
3
C-Reactive Protein
IBA
11/2023 - 03/2012
3
Clopidogrel (Plavix)
FDA Link
02/2023 - 01/2016
3
Anticoagulants
IBA
02/2023 - 01/2021
3
LDL Cholesterol
IBA
01/2023 - 08/2021
3
Lipids
IBA
01/2023 - 11/2014
2
Interleukin-6 (Interleukin 6)
IBA
11/2023 - 11/2023
2
omega-Chloroacetophenone (Mace)
IBA
09/2023 - 01/2023
2
Warfarin (Coumadin)
FDA Link
Generic
01/2021 - 08/2010
2
Glucose (Dextrose)
FDA Link
Generic
07/2014 - 03/2012
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
11/2023
1
Cytokines
IBA
11/2023
1
Particulate Matter
IBA
01/2023
1
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
10/2022
1
danaparoid (Orgaran)
FDA Link
01/2022
1
LDL Lipoproteins (beta Lipoproteins)
IBA
08/2021
1
Rivaroxaban
IBA
01/2021
1
Dabigatran
FDA Link
01/2021
1
Phosphates (Orthophosphate)
IBA
01/2021
1
Vitamin K
FDA Link
01/2021
1
apixaban
IBA
01/2021
1
edoxaban
IBA
01/2021
1
Albumins
IBA
01/2021
1
Calcium
IBA
01/2021
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
09/2019
1
Blood Glucose (Blood Sugar)
IBA
09/2019
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2016
1
Fibrinolytic Agents (Antithrombotic Agents)
IBA
08/2015
1
Yindan Xinnaotong
IBA
11/2014
1
Antihypertensive Agents (Antihypertensives)
IBA
02/2013
1
MicroRNAs (MicroRNA)
IBA
12/2012
1
Homocysteine
IBA
03/2012
Therapy/Procedure
11
Therapeutics
11/2023 - 10/2008
8
Secondary Prevention
11/2023 - 10/2008
2
Length of Stay
02/2023 - 04/2021
1
Treatment Delay
01/2023
1
Time-to-Treatment
01/2022
1
Stents
10/2008
1
Contraindications
10/2008